Non ischemic
Post-transcriptional modifications of VEGF-A mRNA in non-ischemic dilated cardiomyopathy
17
Effect of stopping beta-blockers on lv remodeling in non-ischemic cardiomyopathy patients with normalisation of lv function: a 12 month study
5
Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non ischemic cardiomyopathy
9
Preliminary clinical study of left ventricular myocardial strain in patients with non-ischemic dilated cardiomyopathy by three-dimensional speckle tracking imaging
9
Effects of autologous bone marrow stem cell transplantation on beta-adrenoceptor density and electrical activation pattern in a rabbit model of non-ischemic heart failure
11
Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
17
Non-inflammatory or non-ischemic vascular gas on emergent multi-detector computed tomography: Eight years' experience
8
Comparison of mitral annulus geometry between patients with ischemic and non-ischemic functional mitral regurgitation: implications for transcatheter mitral valve implantation
10
Community detection of non ischemic stage B heart failure
310
Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart disease
21
Mechanical effects of left ventricular midwall fibrosis in non ischemic cardiomyopathy
8
A portable prototype magnetometer to differentiate ischemic and non-ischemic heart disease in patients with chest pain
10
NYHA Class II or III Heart Failure: Who Will Need an Implantable Cardioverter Defibrillator (ICD)?
11
Non Arteritic Anterior Ischemic Optic Neuropathy (NAION)—A Brief Review
7
Left ventricular systolic function and the pattern of late gadolinium enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients
13
Role of receptor for advanced glycation end products (RAGE) in liver disease
7
Left ventricular mechanics in advanced heart failure patients
225
Vol 9 (2016)
5
Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance
5
Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy
7